Literature DB >> 16866093

Advances and challenges in diagnosis and management of skeletal metastases.

Panayiotis J Papagelopoulos1, Olga D Savvidou, Evanthia C Galanis, Andreas F Mavrogenis, David J Jacofsky, Frank J Frassica, Franklin H Sim.   

Abstract

The treatment of metastatic disease remains challenging. The number of patients who will be diagnosed with metastatic bone disease will continue to increase as survival from the primary cancer diagnosis continues to improve. Although it often is impossible to cure these patients, the task of maximizing their quality of life must be met with valiant efforts. Although a large number of medical and technological advances have occurred, perhaps the recognition of the importance of a well-qualified multidisciplinary team approach to treatment of these complex patients has done more to improve the field than any other single achievement. As basic science continues to further unravel potential treatment options, we must not forget this integrated approach and we must embrace "the bench" at the bedside.

Entities:  

Mesh:

Year:  2006        PMID: 16866093     DOI: 10.3928/01477447-20060701-01

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  11 in total

1.  Long-term outcomes of cement in cement technique for revision endoprosthesis surgery.

Authors:  Nicholas M Bernthal; Vishal Hegde; Stephen D Zoller; Howard Y Park; Jason H Ghodasra; Daniel Johansen; Frederick Eilber; Fritz C Eilber; Chandhanarat Chandhanayingyong; Jeffrey J Eckardt
Journal:  J Surg Oncol       Date:  2017-10-29       Impact factor: 3.454

2.  Surgical technique: Porous tantalum reconstruction for destructive nonprimary periacetabular tumors.

Authors:  Fazel A Khan; Peter S Rose; Michiro Yanagisawa; David G Lewallen; Franklin H Sim
Journal:  Clin Orthop Relat Res       Date:  2011-10-12       Impact factor: 4.176

3.  Application of ex vivo micro-computed tomography for assessment of in vivo fluorescence and plain radiographic imaging for monitoring bone metastases and osteolytic lesions.

Authors:  Sanjay Tiwari; Christian Schem; Ann-Christin Lorenzen; Ole Kayser; Claas Wiese; Christian Graeff; Jaime Peña; Robert P Marshall; Martin Heller; Holger Kalthoff; Walter Jonat; Claus-C Glüer
Journal:  J Bone Miner Metab       Date:  2011-12-02       Impact factor: 2.626

Review 4.  Palliative external-beam radiotherapy for bone metastases from hepatocellular carcinoma.

Authors:  Shinya Hayashi; Hidekazu Tanaka; Hiroaki Hoshi
Journal:  World J Hepatol       Date:  2014-12-27

5.  Prophylactic stabilization for bone metastases, myeloma, or lymphoma: do we need to protect the entire bone?

Authors:  Hasham M Alvi; Timothy A Damron
Journal:  Clin Orthop Relat Res       Date:  2012-10-27       Impact factor: 4.176

6.  Finite element analysis and CT-based structural rigidity analysis to assess failure load in bones with simulated lytic defects.

Authors:  Lorenzo Anez-Bustillos; Loes C Derikx; Nico Verdonschot; Nathan Calderon; David Zurakowski; Brian D Snyder; Ara Nazarian; Esther Tanck
Journal:  Bone       Date:  2013-10-18       Impact factor: 4.398

Review 7.  Bone metastases of unknown origin: epidemiology and principles of management.

Authors:  Andrea Piccioli; Giulio Maccauro; Maria Silvia Spinelli; Roberto Biagini; Barbara Rossi
Journal:  J Orthop Traumatol       Date:  2015-03-01

8.  Clinical Characteristics and Prognostic Factors in Bone Metastases from Lung Cancer.

Authors:  Li Zhang; Zhixin Gong
Journal:  Med Sci Monit       Date:  2017-08-24

9.  Short-term outcomes of en bloc resection of solitary bone metastases in limbs.

Authors:  Qingcheng Yang; Bizeng Zhao; Zhichang Zhang; Yang Dong; Yao Pan; Xinhui Du
Journal:  Med Sci Monit       Date:  2012-11

10.  Comparison of Porous Tantalum Acetabular Implants and Harrington Reconstruction for Metastatic Disease of the Acetabulum.

Authors:  Matthew T Houdek; Peter C Ferguson; Matthew P Abdel; Anthony M Griffin; Mario Hevesi; Kevin I Perry; Peter S Rose; Jay S Wunder; David G Lewallen
Journal:  J Bone Joint Surg Am       Date:  2020-07-15       Impact factor: 6.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.